CIK 0001714899
- Large accelerated filer
Denali Therapeutics Inc.
Sign in to watch- Ticker
- DNLI
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 463872213
- Phone
- +1 650-866-8547
- Business address
- 161 OYSTER POINT BLVD., SOUTH SAN FRANCISCO, CA, 94080
- 4 Open-market sale President and CEO sold 18,333 shares at an average $22.18 ($406,601)
- 4 Open-market sale COO and Secretary sold 7,500 shares at an average $19.08 ($143,089)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Chief Medical Officer sold 17,500 shares at an average $18.72 ($327,589)
- 4 Open-market sale President and CEO sold 18,334 shares at an average $18.72 ($343,300)
- 4 Open-market sale COO and Secretary sold 7,500 shares at an average $20.37 ($152,750)
- 4 Open-market sale Chief Medical Officer sold 14,502 shares at an average $19.55 ($283,506)
- 4 Open-market sale President and CEO sold 18,333 shares at an average $19.43 ($356,288)
- 4 Open-market sale COO and Secretary sold 7,500 shares at an average $20.40 ($153,000)
- 4 Open-market sale Chief Medical Officer sold 17,500 shares at an average $18.45 ($322,834)
- 4 Open-market sale President and CEO sold 18,333 shares at an average $18.43 ($337,938)
- 4 Open-market sale Chief Medical Officer sold 17,500 shares at $18.07 ($316,157)
- 4 Open-market sale President and CEO sold 18,334 shares at an average $18.09 ($331,664)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale President and CEO sold 18,333 shares at $21.72 ($398,193)
- 4 Open-market sale Chief Medical Officer sold 17,500 shares at $21.72 ($380,100)
Page 19 of 22 · 436 filings